Furthermore, the leukemia inhibitory effects of the 3 inhibitors were significantly correlated with each other supporting the proposition that the kinase cascade and NHE1 activity might act on the same axis in AML (Supplementary Fig. S3K). Here, SLC9A1 is linked to leukemia.